Skip to main content

Faith in the Redemptive names of God (34)

Jehovah-Shaphat (The Lord our Judge)
Text: Judges 11:27; Isaiah 33:22

Faith in the Redemptive names of God (34)

By J.K. Akinola. (Senior Pastor)

Introduction

This redemptive name of God is a crucial one, and the last we are treating in this serial, that has a lot of lessons for us to learn in our covenant relationship with God, especially as Christians, unto whom the end of the world has come.

We shall look at this name of God in about 5-part serial, and may the Lord open our eyes to the truths therein and quicken us in accordance to His Word in Jesus name. When bringing issues down to the import of this name as it applies to us today, our Lord Jesus Christ will be seen as the embodiment of this name.

This is because, the Lord Jesus Christ Himself said it in John 5:22-23: “For the Father judgeth no man, but hath committed all judgment unto the Son”.

If God hath committed all judgment into the hands of the Son, for obvious reasons of His redemptive plan, what a shame then it is for anyone who refuses to believe in the Son and His redemptive work. John 3:18 says: “..he that believeth not is condemned already, because he hath not believed on the only begotten Son of God”.

READ ALSO: Faith in the Redemptive names of God (34)

I congratulate you therefore if you have already given your life to Jesus Christ, for you have crossed from death to life, having been freely justified by Him who is the judge of all at His appearing and His Kingdom. (II Timothy 4:1). Let us therefore go out and proclaim Him to the sinners. He comes quickly with His rewards. (Revelation 22:12).

Analysis of the Old Testament Jeho-shaphat (Jehovah Judges)

At the heart of every judicial system is a law, and this law is strictly administered and enforced if the society is not to disintegrate. Right from the time Moses met God on Mount Sinai, God gave laws for His people, that they might keep them and thereby be a peculiar treasure unto Him among the peoples of the earth. (Exodus 19:5).

It is however a matter of history how God’s people failed many times and therefore fell into terrible judgments even in the hands of those before whom God wanted to showcase them.

King Jehoshaphat was one of the kings of Judah who initiated reforms of returning to God’s laws as the basis of a true and lasting governance. God is no respecter of persons, and His scales are just. Deuteronomy 32:4.

In the next serial, we shall observe some things about Jehoshaphat, which, despite his zeal for God’s law and His service, he was not covered by God when he strayed off course! Our God is just. He could not find anyone among mortals who could stand as the lawgiver and fulfilment, until Shiloh came, according to the prophecy of Jacob in Genesis 49:10.

“The sceptre shall not depart from Judah, nor a lawgiver from between his feet, until Shiloh come, and unto Him shall the gathering of the people be”.

Vanguard Nigeria News

The post Faith in the Redemptive names of God (34) appeared first on Vanguard News.


by David O Royal via Vanguard News https://ift.tt/2Pw2JSv Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more